Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/early-covid-19-testing-is-critical-to-end-the-pandemic-wWuDu2InWF
References (25)
-
COVID-19 Guidance: Primary Care Providers in a Community Setting -
( Shimizu K , Negita M . Lessons learned from Japan's response to the first wave of COVID‐19: a content analysis. Healthcare (Basel). 2020;8(4):426. 10.3390/healthcare8040426 )
Shimizu K , Negita M . Lessons learned from Japan's response to the first wave of COVID‐19: a content analysis. Healthcare (Basel). 2020;8(4):426. 10.3390/healthcare8040426Shimizu K , Negita M . Lessons learned from Japan's response to the first wave of COVID‐19: a content analysis. Healthcare (Basel). 2020;8(4):426. 10.3390/healthcare8040426 , Shimizu K , Negita M . Lessons learned from Japan's response to the first wave of COVID‐19: a content analysis. Healthcare (Basel). 2020;8(4):426. 10.3390/healthcare8040426
-
Kazuki Shimizu, Masashi Negita (2020)
Lessons Learned from Japan’s Response to the First Wave of COVID-19: A Content AnalysisHealthcare, 8
-
( Ministry of Health , Ontario, Canada. COVID‐19 Guidance: Primary Care Providers in a Community Setting. (Accessed on January 5, 2021) http://www.health.gov.on.ca/en/pro/programs/publichealth/coronavirus/docs/2019_primary_care_guidance.pdf.)
Ministry of Health , Ontario, Canada. COVID‐19 Guidance: Primary Care Providers in a Community Setting. (Accessed on January 5, 2021) http://www.health.gov.on.ca/en/pro/programs/publichealth/coronavirus/docs/2019_primary_care_guidance.pdf.Ministry of Health , Ontario, Canada. COVID‐19 Guidance: Primary Care Providers in a Community Setting. (Accessed on January 5, 2021) http://www.health.gov.on.ca/en/pro/programs/publichealth/coronavirus/docs/2019_primary_care_guidance.pdf., Ministry of Health , Ontario, Canada. COVID‐19 Guidance: Primary Care Providers in a Community Setting. (Accessed on January 5, 2021) http://www.health.gov.on.ca/en/pro/programs/publichealth/coronavirus/docs/2019_primary_care_guidance.pdf.
-
Laboratory testing for coronavirus disease ( COVID - 19 ) in suspected human cases : interim guidance . 19 March 2020 -
( He X , Lau EH , Wu P , et al Author Correction: Temporal dynamics in viral shedding and transmissibility of COVID‐19. Nat Med. 2020;26(9):1491–3. 10.1038/s41591-020-1016-z 32770170)
He X , Lau EH , Wu P , et al Author Correction: Temporal dynamics in viral shedding and transmissibility of COVID‐19. Nat Med. 2020;26(9):1491–3. 10.1038/s41591-020-1016-z 32770170He X , Lau EH , Wu P , et al Author Correction: Temporal dynamics in viral shedding and transmissibility of COVID‐19. Nat Med. 2020;26(9):1491–3. 10.1038/s41591-020-1016-z 32770170, He X , Lau EH , Wu P , et al Author Correction: Temporal dynamics in viral shedding and transmissibility of COVID‐19. Nat Med. 2020;26(9):1491–3. 10.1038/s41591-020-1016-z 32770170
-
N. Sethuraman, S. Jeremiah, A. Ryo (2020)
Interpreting Diagnostic Tests for SARS-CoV-2.JAMA
-
R. Evans (2014)
European Centre for Disease Prevention and Control.Nursing standard (Royal College of Nursing (Great Britain) : 1987), 29 9
-
COVID-19 Outpatient Care Guide Version 2 -
( European Centre for Disease Prevention and Control . Testing strategies for SARS‐CoV‐2. (Accessed on January 5, 2021) https://www.ecdc.europa.eu/en/covid‐19/surveillance/testing‐strategies.)
European Centre for Disease Prevention and Control . Testing strategies for SARS‐CoV‐2. (Accessed on January 5, 2021) https://www.ecdc.europa.eu/en/covid‐19/surveillance/testing‐strategies.European Centre for Disease Prevention and Control . Testing strategies for SARS‐CoV‐2. (Accessed on January 5, 2021) https://www.ecdc.europa.eu/en/covid‐19/surveillance/testing‐strategies., European Centre for Disease Prevention and Control . Testing strategies for SARS‐CoV‐2. (Accessed on January 5, 2021) https://www.ecdc.europa.eu/en/covid‐19/surveillance/testing‐strategies.
-
( Sethuraman N , Jeremiah SS , Ryo A . Interpreting diagnostic tests for SARS‐CoV‐2. JAMA. 2020;323(22):2249–51. 10.1001/jama.2020.8259 32374370)
Sethuraman N , Jeremiah SS , Ryo A . Interpreting diagnostic tests for SARS‐CoV‐2. JAMA. 2020;323(22):2249–51. 10.1001/jama.2020.8259 32374370Sethuraman N , Jeremiah SS , Ryo A . Interpreting diagnostic tests for SARS‐CoV‐2. JAMA. 2020;323(22):2249–51. 10.1001/jama.2020.8259 32374370, Sethuraman N , Jeremiah SS , Ryo A . Interpreting diagnostic tests for SARS‐CoV‐2. JAMA. 2020;323(22):2249–51. 10.1001/jama.2020.8259 32374370
-
( World Health Organization . Coronavirus disease (COVID‐19) Q and A. (Accessed on January 5, 2021) https://www.who.int/news‐room/q‐a‐detail/coronavirus‐disease‐covid‐19.)
World Health Organization . Coronavirus disease (COVID‐19) Q and A. (Accessed on January 5, 2021) https://www.who.int/news‐room/q‐a‐detail/coronavirus‐disease‐covid‐19.World Health Organization . Coronavirus disease (COVID‐19) Q and A. (Accessed on January 5, 2021) https://www.who.int/news‐room/q‐a‐detail/coronavirus‐disease‐covid‐19., World Health Organization . Coronavirus disease (COVID‐19) Q and A. (Accessed on January 5, 2021) https://www.who.int/news‐room/q‐a‐detail/coronavirus‐disease‐covid‐19.
-
( Centers for Disease Control and Prevention . Test for Current Infection. (Accessed on January 5, 2021) https://www.cdc.gov/coronavirus/2019‐ncov/testing/diagnostic‐testing.html.)
Centers for Disease Control and Prevention . Test for Current Infection. (Accessed on January 5, 2021) https://www.cdc.gov/coronavirus/2019‐ncov/testing/diagnostic‐testing.html.Centers for Disease Control and Prevention . Test for Current Infection. (Accessed on January 5, 2021) https://www.cdc.gov/coronavirus/2019‐ncov/testing/diagnostic‐testing.html., Centers for Disease Control and Prevention . Test for Current Infection. (Accessed on January 5, 2021) https://www.cdc.gov/coronavirus/2019‐ncov/testing/diagnostic‐testing.html.
-
( Xing Y , Wong GWK , Ni W , Hu X , Xing Q . Rapid response to an outbreak in Qingdao, China. N Engl J Med. 2020;383(23):e129. 10.1056/NEJMc2032361 33207089)
Xing Y , Wong GWK , Ni W , Hu X , Xing Q . Rapid response to an outbreak in Qingdao, China. N Engl J Med. 2020;383(23):e129. 10.1056/NEJMc2032361 33207089Xing Y , Wong GWK , Ni W , Hu X , Xing Q . Rapid response to an outbreak in Qingdao, China. N Engl J Med. 2020;383(23):e129. 10.1056/NEJMc2032361 33207089, Xing Y , Wong GWK , Ni W , Hu X , Xing Q . Rapid response to an outbreak in Qingdao, China. N Engl J Med. 2020;383(23):e129. 10.1056/NEJMc2032361 33207089
-
( Japan Primary Care Association . COVID‐19 Primary Care Guidance Version 3. (Accessed on January 5, 2021) https://www.pc‐covid19.jp/files/guidance/guidance‐3.0.pdf.)
Japan Primary Care Association . COVID‐19 Primary Care Guidance Version 3. (Accessed on January 5, 2021) https://www.pc‐covid19.jp/files/guidance/guidance‐3.0.pdf.Japan Primary Care Association . COVID‐19 Primary Care Guidance Version 3. (Accessed on January 5, 2021) https://www.pc‐covid19.jp/files/guidance/guidance‐3.0.pdf., Japan Primary Care Association . COVID‐19 Primary Care Guidance Version 3. (Accessed on January 5, 2021) https://www.pc‐covid19.jp/files/guidance/guidance‐3.0.pdf.
-
Xi He, E. Lau, P. Wu, Xilong Deng, Jian Wang, Xinxin Hao, Y. Lau, J. Wong, Y. Guan, Xinghua Tan, Xiao-Neng Mo, Yan-qing Chen, B. Liao, Weilie Chen, F. Hu, Qing Zhang, M. Zhong, Yanrong Wu, Ling-Zhai Zhao, Fuchun Zhang, B. Cowling, Fang Li, G. Leung (2020)
Temporal dynamics in viral shedding and transmissibility of COVID-19Nature Medicine, 26
-
Xi He, E. Lau, P. Wu, Xilong Deng, Jian Wang, Xinxin Hao, Y. Lau, J. Wong, Y. Guan, Xinghua Tan, Xiao-Neng Mo, Yan-qing Chen, B. Liao, Weilie Chen, F. Hu, Qing Zhang, M. Zhong, Yanrong Wu, Ling-Zhai Zhao, Fuchun Zhang, B. Cowling, Fang Li, G. Leung (2020)
Author Correction: Temporal dynamics in viral shedding and transmissibility of COVID-19Nature Medicine, 26
-
British Columbia Centre for Disease Control -
Yuhan Xing, G. Wong, W. Ni, Xiaowen Hu, Q. Xing (2020)
Rapid Response to an Outbreak in Qingdao, ChinaThe New England Journal of Medicine
-
Japan Primary Care Association. COVID-19 Primary Care Guidance Version 3 -
World Health Organization. Coronavirus disease (COVID-19) Q and A. (Accessed on -
( Tokuda Y , Shibuya K , Oguro K . Priority of SARS‐CoV‐2 test, trace, and isolation in Japan. J Gen Fam Med. 2020;22(1):1–2. 10.1002/jgf2.409. )
Tokuda Y , Shibuya K , Oguro K . Priority of SARS‐CoV‐2 test, trace, and isolation in Japan. J Gen Fam Med. 2020;22(1):1–2. 10.1002/jgf2.409.Tokuda Y , Shibuya K , Oguro K . Priority of SARS‐CoV‐2 test, trace, and isolation in Japan. J Gen Fam Med. 2020;22(1):1–2. 10.1002/jgf2.409. , Tokuda Y , Shibuya K , Oguro K . Priority of SARS‐CoV‐2 test, trace, and isolation in Japan. J Gen Fam Med. 2020;22(1):1–2. 10.1002/jgf2.409.
-
Y. Tokuda, K. Shibuya, Kazumasa Oguro (2020)
Priority of SARS‐CoV‐2 test, trace, and isolation in JapanJournal of General and Family Medicine, 22
-
(2021)
interim guidance -
( Japan Medical Association . COVID‐19 Outpatient Care Guide Version 2. (Accessed on January 5, 2021) https://www.med.or.jp/dl‐med/kansen/novel_corona/shinryoguide_ver2.pdf.)
Japan Medical Association . COVID‐19 Outpatient Care Guide Version 2. (Accessed on January 5, 2021) https://www.med.or.jp/dl‐med/kansen/novel_corona/shinryoguide_ver2.pdf.Japan Medical Association . COVID‐19 Outpatient Care Guide Version 2. (Accessed on January 5, 2021) https://www.med.or.jp/dl‐med/kansen/novel_corona/shinryoguide_ver2.pdf., Japan Medical Association . COVID‐19 Outpatient Care Guide Version 2. (Accessed on January 5, 2021) https://www.med.or.jp/dl‐med/kansen/novel_corona/shinryoguide_ver2.pdf.
- Publisher
- Wiley
- Copyright
- © 2021 Japan Primary Care Association
- eISSN
- 2189-7948
- DOI
- 10.1002/jgf2.420
- Publisher site
- See Article on Publisher Site
Abstract
Journal
Journal of General and Family Medicine – Wiley
Published: Mar 1, 2021